- Malaysia
- /
- Healthcare Services
- /
- KLSE:ALPHA
Alpha IVF Group Berhad Full Year 2024 Earnings: EPS Beats Expectations
Alpha IVF Group Berhad (KLSE:ALPHA) Full Year 2024 Results
Key Financial Results
- Revenue: RM167.6m (up 22% from FY 2023).
- Net income: RM52.9m (flat on FY 2023).
- Profit margin: 32% (down from 39% in FY 2023). The decrease in margin was driven by higher expenses.
- EPS: RM0.012 (down from RM0.015 in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Alpha IVF Group Berhad EPS Beats Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 4.5%.
The primary driver behind last 12 months revenue was the Malaysia segment contributing a total revenue of RM135.5m (81% of total revenue). The largest operating expense was General & Administrative costs, amounting to RM24.5m (55% of total expenses). Explore how ALPHA's revenue and expenses shape its earnings.
Looking ahead, revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 6.0% growth forecast for the Healthcare industry in Malaysia.
Performance of the Malaysian Healthcare industry.
The company's shares are down 2.7% from a week ago.
Risk Analysis
Don't forget that there may still be risks. For instance, we've identified 1 warning sign for Alpha IVF Group Berhad that you should be aware of.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About KLSE:ALPHA
Alpha IVF Group Berhad
Operates as a fertility care specialist that focuses on the provision of assisted reproductive services in Malaysia and Singapore.
Flawless balance sheet with high growth potential.
